Results for tag: "Mitral Valve Insufficiency Drug"

The Mitral Valve Insufficiency Drug market is a subset of the Cardiovascular Drugs market. It is composed of drugs used to treat mitral valve insufficiency, a condition in which the mitral valve does not close properly, allowing blood to flow backward into the left atrium. These drugs are used to reduce the symptoms of mitral valve insufficiency, such as shortness of breath, fatigue, and chest pain. Commonly prescribed drugs include ACE inhibitors, beta blockers, and diuretics. In some cases, surgery may be necessary to repair the valve. The Mitral Valve Insufficiency Drug market is highly competitive, with many companies offering products to treat the condition. Some of the major players in the market include Pfizer, Merck, Novartis, Sanofi, and GlaxoSmithKline. Show Less Read more